Drug Patent Watch
FEBRUARY 5, 2025
The Latin American Pharmaceutical Market: Why Specialty Generics Are Poised for Growth As the pharmaceutical industry continues to evolve, one trend is becoming increasingly clear: the demand for specialty generics is on the rise, particularly in the Latin American market. But what exactly are specialty generics, and why are they gaining traction in this region?
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 5, 2025
(courtneyk/Getty Images) Research on the gut microbiome has triggered a ‘revolution‘ in nutritional science, and in the last few years, dietary fiber has become the “new protein” added to foods in abundance to feed our gut and boost our health. A recent study on mice, however, suggests not all fiber supplements are equally beneficial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 5, 2025
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.
ACRP blog
FEBRUARY 5, 2025
As many as 20% to 50% of clinical trials do not accrue participants at the site level, leading to wasted time and financial resources. This waste can be minimized by early selection of trials most likely to succeed. The protocol feasibility review process informs this selection by offering a way to evaluate logistical elements of a clinical trial before the activation process is started.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
FEBRUARY 5, 2025
CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer duration in the new trial.
XTalks
FEBRUARY 5, 2025
Metsera, Inc., a clinical-stage biotech company focused on developing next-gen injectable and oral nutrient-stimulated hormone (NuSH) analog peptides for the treatment of obesity, overweight and related conditions, has priced its initial public offering (IPO) at $18.00 per share, raising $275 million in gross proceeds. Current Share Price: The offering, which includes 15,277,778 shares of common stock, is set to close on February 3, 2025, after beginning trading on the Nasdaq under the ticker sy
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
FEBRUARY 5, 2025
X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.
Bio Pharma Dive
FEBRUARY 5, 2025
The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.
Pharmaceutical Technology
FEBRUARY 5, 2025
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth.
Antidote
FEBRUARY 5, 2025
In an increasingly competitive market, organizations involved in clinical trials or participant-driven research programs cannot afford to have a cumbersome or confusing recruitment and enrollment process. A seamless, efficient, and supportive experiencefrom first contact to trial participationcan make all the difference in attracting and retaining participants, ultimately ensuring the success of your trial.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
FEBRUARY 5, 2025
Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on trials.
XTalks
FEBRUARY 5, 2025
In this episode, Ayesha spoke with Mario Marcondes, MD, PhD, VP Head of Clinical Development at Nektar Therapeutics , a company focused on the discovery and development of novel therapies for autoimmune disorders and cancer. Dr. Marcondes is a licensed and trained physician, specializing in oncology and immune oncology. He has more than 15 years of research and teaching experience in Bone Marrow Transplant (BMT)/Cellular Therapies and more than 10 years of industry experience.
Pharmaceutical Technology
FEBRUARY 5, 2025
Valnevas chikungunya vaccine Ixchiq has been greenlit by the UKs MHRA, allowing the single-dose vaccine to be made available for adults.
ProRelix Research
FEBRUARY 5, 2025
Integrating E-Clinical Technologies in smarter clinical trials improves efficiency, enhances data accuracy, and streamlines clinical research for better patient outcomes. With the increasing world population, clinical trials are now more […] The post The Role of Integrating E-Clinical Technologies In Smarter Clinical Trials appeared first on ProRelix Research.
Pharmaceutical Technology
FEBRUARY 5, 2025
Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.
Pharma Times
FEBRUARY 5, 2025
Breast cancer therapy offers hope for patients at risk of recurrence
Pharmaceutical Technology
FEBRUARY 5, 2025
MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth.
pharmaphorum
FEBRUARY 5, 2025
Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
FEBRUARY 5, 2025
During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a detailed review of its achievements in 2024 and outlining its 2025 plans.
pharmaphorum
FEBRUARY 5, 2025
Robert F Kennedy Jr has cleared a key obstacle in his bid to become the next HHS Secretary after the Senate Finance Committee voted in his favour.
Pharmaceutical Technology
FEBRUARY 5, 2025
Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).
pharmaphorum
FEBRUARY 5, 2025
Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to 40 billion in 2031.
Pharmaceutical Commerce
FEBRUARY 5, 2025
The company cites a decline in sales and excess inventory as the main contributing factors.
pharmaphorum
FEBRUARY 5, 2025
The renaissance of Roche's refillable ophthalmic implant Susvimo has continued with FDA approval for use in patients with diabetic macular oedema
Pharmaceutical Commerce
FEBRUARY 5, 2025
The latest news for pharma industry insiders.
pharmaphorum
FEBRUARY 5, 2025
Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Commerce
FEBRUARY 5, 2025
In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, shares how the imposed/pending trade tariffs impact pharma manufacturers.
Sciensano
FEBRUARY 5, 2025
Emerging animal diseases Event type: symposium Audience: scientists Description: Sciensano organises together with the Federal Agency for the Safety of the Food Chain ( FASFC ), ARSIA and DGZ , the 10th symposium on animal health. The spoken language of this event is Dutch or French. Hence, more information about this course can be found on the Dutch or French version of the event page.
Trialfacts
FEBRUARY 5, 2025
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Center Study Location Research Center: Baylor College of Medicine Location: 1977 Butler Blvd Houston Texas 77030 Lead Researcher: Sanjay J. Mathew, M.D. IRB: This study has been reviewed and approved by the Baylor College of Medicine Institutional Review Board About the Study Could brain imaging hold the key to more effective PTSD treatments?
Velocity Clinical Research
FEBRUARY 5, 2025
Thank you to SCOPE Summit for recognizing Velocity at the 2025 Site Innovation Award presentation! Our presentation focused on the way VISION is enhancing trial accessibility for participants worldwide. Now available in four countries and four languages, the VISION Engage mobile app has been downloaded more than 100,000 times. To date, VISION has supported: 8,700 randomizations $5.3M in-app patient stipend payments Continuous data refinement on 1.5M patients Learn more about VISION > The
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
93 
Let's personalize your content